Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Biosimilar Red Tape Elimination Act
Client: SUN PHARMACEUTICAL INDUSTRIES, INC. · Firm: SUN PHARMACEUTICAL INDUSTRIES, INC.
H.R. 5526 - Biosimilar Red Tape Elimination Act; all provisions. S. 1414 - Expedited Access to Biosimilars Act; all provisions. S. 2658 - Medication Affordability and Patent Integrity Act; all provisions.
Expedited Access to Biosimilars Act
Client: SUN PHARMACEUTICAL INDUSTRIES, INC. · Firm: SUN PHARMACEUTICAL INDUSTRIES, INC.
H.R. 5526 - Biosimilar Red Tape Elimination Act; all provisions. S. 1414 - Expedited Access to Biosimilars Act; all provisions. S. 2658 - Medication Affordability and Patent Integrity Act; all provisions.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SUN PHARMACEUTICAL INDUSTRIES, INC. via SUN PHARMACEUTICAL INDUSTRIES, INC.
2026 · third_quarter · Q3
Issues related to Section 232 pharmaceutical tariffs.
H.R. 5526 - Biosimilar Red Tape Elimination Act; all provisions. S. 1414 - Expedited Access to Biosimilars Act; all provisions. S. 2658 - Medication Affordability and Patent Integrity Act; all provisions.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Medication Affordability and Patent Integrity Act
Client: SUN PHARMACEUTICAL INDUSTRIES, INC. · Firm: SUN PHARMACEUTICAL INDUSTRIES, INC.
H.R. 5526 - Biosimilar Red Tape Elimination Act; all provisions. S. 1414 - Expedited Access to Biosimilars Act; all provisions. S. 2658 - Medication Affordability and Patent Integrity Act; all provisions.
SUN PHARMACEUTICAL INDUSTRIES, INC. via SUN PHARMACEUTICAL INDUSTRIES, INC.
2026 · third_quarter · RR
232 tariffs, drug pricing
232 tariffs, drug pricing
232 tariffs, drug pricing